🇺🇸 FDA
Pipeline program

15-Valent Pneumococcal Conjugate Vaccine

201807001

Phase 1 mab active

Quick answer

15-Valent Pneumococcal Conjugate Vaccine for Pneumonia, Pneumococcal is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Pneumonia, Pneumococcal
Phase
Phase 1
Modality
mab
Status
active

Clinical trials